Dillon & Associates’s Rockwell Medical RMTI Stock Holding History

Dillon & Associates’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-104	Closed	-$5K	–	76
2022 Q1	$5K	Hold	104	–	–	﹤0.01%	78
2021 Q4	$5K	Hold	104	–	–	﹤0.01%	78
2021 Q3	$7K	Hold	104	–	–	﹤0.01%	72
2021 Q2	$10K	Hold	104	–	–	﹤0.01%	71
2021 Q1	$11K	Hold	104	–	–	﹤0.01%	72
2020 Q4	$11K	Hold	104	–	–	﹤0.01%	66
2020 Q3	$12K	Hold	104	–	–	﹤0.01%	67
2020 Q2	$23K	Hold	104	–	–	0.01%	68
2020 Q1	$23K	Hold	104	–	–	0.01%	63
2019 Q4	$23K	Hold	104	–	–	0.01%	67
2019 Q3	$34K	Buy	+104	New	+$32K	0.01%	66
2013 Q3	–	Sell	-94	Closed	-$41K	–	64
2013 Q2	$41K	Buy	+94	New	+$39.8K	0.03%	58

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Dillon & Associates's RMTI Position: Q2 2022 in Review

Dillon & Associates sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 104 shares — an estimated $5K sold.

Dillon & Associates first reported a position in RMTI in Q2 2013 and held it in 12 quarters. The position peaked at $41K in Q2 2013. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.

Dillon & Associates reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
Dillon & Associates sold 104 Rockwell Medical shares in Q2 2022, an estimated $5K.
Dillon & Associates first reported a position in Rockwell Medical in Q2 2013 and held it in 12 quarters.
Dillon & Associates's Rockwell Medical position peaked at $41K in Q2 2013.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.

Based on Dillon & Associates's 13F filing for Q2 2022, filed 26 Jul 2022.